William Harlan, MD
Gastroenterology · Asheville, NCNPI 1003806043
Payments from drug & device makers
Across 355 payments — averaging $3942.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$612K
- AbbVie$233K
- Genentech, Inc.$135K
- Eli Lilly$112K
- Janssen Research & Development, LLC$92K
- Bristol Myers Squibb$91K
- plus $124K from 27 others
Across 1 payment — averaging $1015.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $612,474 |
| AbbVie | 167 | $233,024 |
| Genentech, Inc. | 33 | $135,393 |
| Eli Lilly | 4 | $111,998 |
| Janssen Research & Development, LLC | 19 | $91,557 |
| Bristol Myers Squibb | 19 | $91,187 |
| Gilead | 15 | $49,107 |
| Astrazeneca UK Limited | 1 | $30,392 |
| Braintree Laboratories, Inc. | 8 | $13,610 |
| Bausch Health US, LLC | 6 | $12,638 |
| F. Hoffmann-la Roche AG | 2 | $9,886 |
| Ferring Pharmaceuticals AS | 1 | $6,000 |
| Johnson & Johnson | 4 | $753 |
| QOL Medical, LLC | 6 | $168 |
| Sanofi | 2 | $163 |
| Enterra Medical, Inc. | 1 | $145 |
| Ardelyx, Inc. | 2 | $144 |
| Fujifilm Healthcare Americas Corporation | 1 | $119 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Pfizer | 7 | $112 |
| Cook Medical LLC | 1 | $77 |
| Ironwood Pharmaceuticals, Inc | 4 | $62 |
| Phathom Pharmaceuticals, Inc. | 4 | $53 |
| Madrigal Pharmaceuticals | 2 | $51 |
| Olympus America Inc. | 2 | $41 |
| Boehringer Ingelheim International GmbH | 1 | $34 |
| Pentax Of America, Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Laborie Medical Technologies Corp. | 1 | $26 |
| Covidien LP | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
How this compares
$1,399,482 in reported general payments places this provider in the 95th percentile of 610 gastroenterology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Asheville
- Adam ZivonyAsheville$1.1M
- Brian GarvinAsheville$150K
- Evan DellonChapel Hill$11.2M
- Andrew MuirDurham$6.6M
- Manal AbdelmalekDurham$5.6M
- Robert ReindollarSalisbury$2.5M
- John PoulosFayetteville$2.1M
- Hans HerfarthChapel Hill$2M
- Herbert BonkovskyWinston Salem$1.7M
- Ikechukwu IbegbuJacksonville$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.